# FDA 483 - Daniel Fred Goodman, M.D. - December 13, 2021

Source: https://www.keypedia.com/records/483/daniel-fred-goodman-md/317bef58-c03c-4dc7-b1c4-831ec0289166

> FDA 483 for Daniel Fred Goodman, M.D. on December 13, 2021. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Daniel Fred Goodman, M.D.
- Inspection Date: 2021-12-13
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West V
- Summary: Daniel Fred Goodman, M.D., a sponsor-investigator in San Francisco, CA, was cited for multiple significant violations during an FDA inspection. The inspection revealed serious deficiencies in the conduct of a Phase 1 clinical investigation, primarily concerning informed consent procedures, protocol adherence, investigational drug accountability, and regulatory reporting. These issues indicate a severe lack of oversight and compliance with clinical trial regulations.

## Related Documents

- [483 - 2024-11-25](https://www.keypedia.com/records/483/daniel-fred-goodman-md/1ba20ce0-0f7f-4212-a7e0-54ef4c603d0d)

## Related Officers

- [Kristin M. Abaonza](https://www.keypedia.com/people/kristin-m-abaonza/cf909da8-837d-4dfe-9ccc-288b24d7bba3)

Company: https://www.keypedia.com/companies/daniel-fred-goodman-md/75721ae4-0e50-488f-bbb5-22b050bc0249

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-west-v/0f4dd01e-8e8a-4336-9abe-ce8b3d309e8b